Tandem Diabetes Care Inc (FRA:TD5A)
€ 46.5 -0.61 (-1.29%) Market Cap: 3.09 Bil Enterprise Value: 3.10 Bil PE Ratio: 0 PB Ratio: 13.74 GF Score: 77/100

Tandem Diabetes Care Inc at Stifel Healthcare Conference Transcript

Nov 16, 2022 / 09:45PM GMT
Release Date Price: €40.61 (+0.36%)
Mathew Justin Blackman
Stifel, Nicolaus & Company, Incorporated, Research Division - Analyst

All right. Good afternoon, everybody. Thank you again for participating and joining us here at the Stifel 2022 Healthcare Conference. I believe this is the final session of the day. You've made it through. I hope it's been productive. And we're going to go out with a bang. We've got a great final session for you. I've got Tandem Diabetes, senior management. John Sheridan, President and CEO on my left; and my far left, Leigh Vosseller, Executive Vice President and CFO. As always, if you folks have questions, please don't hesitate. Raise your hand, and we'll incorporate into the conversation. And thank you both for (inaudible).

John F. Sheridan
Tandem Diabetes Care, Inc. - President, CEO & Director

Absolutely. Thanks for having us.

Mathew Justin Blackman;John F. Sheridan
Stifel, Nicolaus & Company, Incorporated, Research Division - Analyst;Tandem

You made a very long trip.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot